Authors
Latest:
How to Choose the Right Approach to Enhance Drug SolubilityWhat is the correct approach for formulation development of poorly soluble NCEs? Dr. Umesh Barabde, director and operations head, Pharmaceutical Development Services, and Dr. Vishakh Kharat, director, analytical research, Pharmaceutical Development Services, both at Piramal Pharma Solutions discuss classic and specialized techniques to enhance solubility. Live: Thursday, Jun. 25, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after final airing Jun. 25, 2021 Register free
Latest:
Excipient-Binder Scale for Direct Compression and Dry Granulation TabletingA present investigation aimed to evaluate the impact of commonly used different binder-diluent ratios on the tablet's mechanical strength to propose a binder-diluent scale.
Latest:
Integrated Preformulation Studies for Fast Advancement of Drug Candidates to Human Clinical StudiesScreening for developability and solubility issues Assessing pH and food effect when evaluating bioavailability Addressing solubility challenges
Latest:
Selecting a Specimen Holder for X-ray Powder DiffractionSpecimen mounting in x-ray powder diffraction affects peak positions and intensities.
Latest:
Overcoming Operational and Regulatory Challenges in Autologous Cell-Therapy FacilitiesManufacturers must address scale-out challenges of autologous cell therapy for commercial manufacturing.
Latest:
Quality Quartets in Risk-Based Qualification: ICH Q9(R1) ConsiderationsQuality Quartets may be used to achieve knowledge-driven, risk-based approaches to commissioning and qualification that are consistent with ICH Q9(R1) principles.
